Drug Profile
SNAP 5258
Latest Information Update: 20 Aug 2007
Price :
$50
*
At a glance
- Originator Lundbeck Research USA
- Class Antiepileptic drugs; Anxiolytics; Neuroprotectants
- Mechanism of Action GABA uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Epilepsy; Insomnia
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Anxiety disorders in USA (Unknown route)
- 02 Sep 1998 No-Development-Reported for Epilepsy in USA (Unknown route)
- 02 Sep 1998 No-Development-Reported for Insomnia in USA (Unknown route)